Pulse Biosciences Appoints Burke T. Barrett As President and CEO, and Kevin Danahy As Chief Commercial Officer
May 14, 2024•about 1 year ago
Position
Chief Commercial Officer
Company
Pulse Biosciences, Inc.
Description
Pulse Biosciences announced the appointment of Burke T. Barrett as President and Chief Executive Officer, while Kevin Danahy, former President and Chief Executive Officer, has been appointed as the Chief Commercial Officer to lead the pilot launch of the recently FDA cleared CellFX nsPFA Percutaneous Electrode System.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months